NVIDIA enterprise generative AI platform supercharging biomolecular discovery, protein design, and molecular dynamics.
Life science researchers can request developer access to interactive cloud microservices
NVIDIA BioNeMo is a generative AI platform purpose-built for accelerated drug discovery and computational biology. A flagship component of the NVIDIA Clara healthcare suite, BioNeMo packages premier biological foundation models including AlphaFold, DiffDock, and ESM into containerized cloud-native microservices called NIMs. Powered by NVIDIA accelerated computing, biopharma researchers can execute candidate generation, molecular docking, and target identification at unprecedented scale.